Skip to main content

. 1962 Apr;40(4):393–423.

The Pathologic Anatomy and Pathogenesis of Fatal Human Leptospirosis (Weil's Disease)

PMCID: PMC1949541 PMID: 13862141

393

Images in this article

Fig. 1
on p.415

Fig. 2
on p.415

Fig. 3
on p.415

Fig. 4
on p.415

Fig. 5
on p.415

Fig. 6-10
on p.417

Figs. 11-16
on p.419

Figs. 17-20
on p.421

Figs. 21-25
on p.423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

AREAN V. M. Leptospiral myocarditis. Lab Invest. 1957 Sep-Oct;6(5):462–471. [PubMed] [Google Scholar]
AUSTONI M., BARUFFALDI O. Contributo ad una piu completa conoscenza di lesioni anatomo-istologiche nel m. di Weil e valutazione delle stesse in ordine alla sindrome epato-renale. Arch Maragliano Patol Clin. 1951 Jan-Feb;6(1):135–152. [PubMed] [Google Scholar]
BENHAMOU E., TIMSIT M., AKOUN G. Premier cas nord-africain de leptospirose canicolaire et premier cas de miliaire pulmonaire due à Leptospira canicola. Bull Mem Soc Med Hop Paris. 1955 Oct 14;71(23-24):923–930. [PubMed] [Google Scholar]
BENNETT I. L., Jr, CLUFF L. E. Bacterial pyrogens. Pharmacol Rev. 1957 Dec;9(4):427–479. [PubMed] [Google Scholar]
BOYD D. H. Leptospirosis canicola presenting as pneumonia. Br J Dis Chest. 1960 Jan;54:91–92. doi: 10.1016/s0007-0971(60)80050-2. [DOI] [PubMed] [Google Scholar]
CORA D. La funzionalità renale nel morbo di Weil. G Clin Med. 1956 Sep;37(9):1295–1311. [PubMed] [Google Scholar]
DIAZ RUBIO M., JANER DEL VALLE C. La electroforesis en papel de las proteínas y lípidos del suero en la enfermedad de Weil. Rev Clin Esp. 1958 Sep 15;70(5):291–296. [PubMed] [Google Scholar]
EDWARDS G. A. Clinical characteristics of leptospirosis; observations based on a study of twelve sporadic cases. Am J Med. 1959 Jul;27(1):4–17. doi: 10.1016/0002-9343(59)90056-7. [DOI] [PubMed] [Google Scholar]
EDWARDS G. A., DOMM B. M. Human leptospirosis. Medicine (Baltimore) 1960 Feb;39:117–156. doi: 10.1097/00005792-196002000-00003. [DOI] [PubMed] [Google Scholar]
GALTON M. M., MENGES R. W., STEELE J. H. Epidemiological patterns of leptospirosis. Ann N Y Acad Sci. 1958 Jun 3;70(3):427–444. doi: 10.1111/j.1749-6632.1958.tb35401.x. [DOI] [PubMed] [Google Scholar]
GALTON M. M. The epidemiology of leptospirosis in the United States. Public Health Rep. 1959 Feb;74(2):141–148. [PMC free article] [PubMed] [Google Scholar]
HARRIS-SMITH P. W., SMITH H., KEPPIE J. Production in vitro of the toxin of Bacillus anthracis previously recognized in vivo. J Gen Microbiol. 1958 Aug;19(1):91–103. doi: 10.1099/00221287-19-1-91. [DOI] [PubMed] [Google Scholar]
Hume W. E., Szekely P. CARDIAC INVOLVEMENT IN SPIROCHAETAL JAUNDICE. Br Heart J. 1944 Jul;6(3):135–138. doi: 10.1136/hrt.6.3.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
IMAMURA S., KURIBAYASHI K., KAMETA M. Studies on toxins of pathogenic leptospira. Jpn J Microbiol. 1957 Jan;1(1):43–47. doi: 10.1111/j.1348-0421.1957.tb00006.x. [DOI] [PubMed] [Google Scholar]
KALZ G. The human leptospiroses. Am J Med Sci. 1957 Mar;233(3):320–333. [PubMed] [Google Scholar]
KLATSKIN G. Leptospirosis. Yale J Biol Med. 1955 Feb;27(4):243–266. [PMC free article] [PubMed] [Google Scholar]
MONTEVERDE A., FUMAGALLI E. [The behavior of glutamic-oxalacetic and glutamic-pyruvic transaminases in leptospirosis]. Minerva Med. 1959 Aug 25;50:2600–2604. [PubMed] [Google Scholar]
Public Health Weekly Reports for May 3, 1907. Public Health Rep. 1907 May 3;22(18):541–581. [PMC free article] [PubMed] [Google Scholar]
RAMOS-MORALES F., DIAZ-RIVERA R. S., CINTRON-RIVERA A. A., RULLAN J. A., BENENSON A. S., ACOSTA-MATIENZO J. The pathogenesis of leptospiral jaundice. Ann Intern Med. 1959 Nov;51:861–878. doi: 10.7326/0003-4819-51-5-861. [DOI] [PubMed] [Google Scholar]
SILVERSTEIN C. M. Pulmonary manifestations of leptospirosis. Radiology. 1953 Sep;61(3):327–334. doi: 10.1148/61.3.327. [DOI] [PubMed] [Google Scholar]
SMITH H., KEPPIE J., STANLEY J. L. The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. Anthracis in vivo. Br J Exp Pathol. 1955 Oct;36(5):460–472. [PMC free article] [PubMed] [Google Scholar]
STERLING K. Hepatic function in Weil's disease. Gastroenterology. 1950 May;15(1 1):52–58. [PubMed] [Google Scholar]
STOCKARD J. L., WOODWARD T. E. Leptospirosis: infections in man. Ann N Y Acad Sci. 1958 Jun 3;70(3):414–420. doi: 10.1111/j.1749-6632.1958.tb35399.x. [DOI] [PubMed] [Google Scholar]
SUTLIFF W. D., SHEPARD R., DUNHAM W. B. Acute Leptospira pomona arthritis and myocarditis. Ann Intern Med. 1953 Jul;39(1):134–140. doi: 10.7326/0003-4819-39-1-134. [DOI] [PubMed] [Google Scholar]
THIRY P., ABLARD G., LARCAN A. Une manifestation rare de leptospirose: la miliaire pulmonaire. Presse Med. 1955 May 14;63(35):729–730. [PubMed] [Google Scholar]
THOMAS L. The physiological disturbances produced by endotoxins. Annu Rev Physiol. 1954;16:467–490. doi: 10.1146/annurev.ph.16.030154.002343. [DOI] [PubMed] [Google Scholar]
VAN THIEL P. H., ENGELBRECHT E. The mode of infection of man with pathogenic leptospirae. Doc Med Geogr Trop. 1957 Mar;9(1):52–57. [PubMed] [Google Scholar]

ACTIONS

PDF (4.8 MB)

RESOURCES